سعر راميدازولاميد قطرة للعين 5مل 2025

Dorzolamide 20 mg/ml + timolol 5 mg/ml sterile ophthalmic solution, 5 ml, by Rameda, Egypt; for lowering intraocular pressure.

• Reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension insufficiently responsive to beta-blockersPopulation: AdultsDailyMed (U.S. National Library of Medicine)

• Most frequent: taste perversion and ocular burning/stinging (up to 30%); conjunctival hyperaemia, blurred vision, superficial punctate keratitis or eye itching (5-15%).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Bronchial asthma or history of asthma, severe COPD.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Sinus bradycardia, second- or third-degree AV block, overt cardiac failure, cardiogenic shock; hypersensitivity to any component.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Systemic beta-blocker effects possible: respiratory reactions including asthma, cardiac failure, masking of hypoglycaemia and thyrotoxicosis, potentiation of muscle weakness.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Dorzolamide is a sulfonamide; sulfonamide-type hypersensitivity reactions may occur. Not recommended in severe renal impairment.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Dorzolamide caused vertebral malformations in rabbits at maternally toxic oral doses; use in pregnancy only if benefit justifies potential fetal risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Timolol is detected in human milk; decide whether to discontinue nursing or the drug.International label, same formulation · DailyMed (U.S. National Library of Medicine)